Key result
This review highlights how the evolutionary properties of RNA and DNA viruses can be leveraged to develop host-oriented antiviral therapies and immunotherapies.
Why the study?
Pathogen resistance and development costs are major challenges in current approaches to antiviral therapy.
Design
Review
Authors
Loading...
Supports host-oriented antiviral strategies; leaves open clinical translation pending prospective validation.
Host-oriented approaches leveraging host-virus co-evolution offer promising biotechnological solutions for antiviral therapy and immunotherapy.
Steven M. Heaton (2019) conducted a review in Viral infections. Host-oriented therapies and immunotherapy was evaluated. This review highlights how the evolutionary properties of RNA and DNA viruses can be leveraged to develop host-oriented antiviral therapies and immunotherapies.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: